---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-001754"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2025-03-20T23:59:59+00:00"
generated_at: "2026-05-24T10:26:40.873547+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals ups ATM sales capacity to $43.5M from $30.2M; $23.75M raised so far

## Summary
- Company increased aggregate sales price under A.G.P. Sales Agreement to $43.5M on March 20, 2025.
- Prior limit was $30.2M; remaining capacity before increase was $6.45M, now total unissued capacity ~$19.75M.
- As of March 20, 2025, 2,522,755 shares sold for gross proceeds of ~$23.75M; 2,944,381 shares outstanding.
- Shares sold under shelf registration S-3 (File 333-279285) that became effective May 17, 2024.

## SEC filing metadata
- accession: 0001683168-25-001754
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2025-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316825001754/0001683168-25-001754-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825001754/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-001754
- JSON: https://secwatch.observer/filing/0001683168-25-001754.json
- Plain text: https://secwatch.observer/filing/0001683168-25-001754.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.